Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Shaoul

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Gastroenterology|June 14, 2019
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive MonitoringAmit Assa, Manar Matar, Dan Turner, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 24, 2020
The Effect of Adalimumab Treatment on Linear Growth in Children With Crohn Disease: A Post-hoc Analysis of the PAILOT Randomized Control TrialManar Matar, Raanan Shamir, Raffi Lev-Zion, et al.
Journal of Crohn'S & Colitis|April 29, 2017
Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled TrialDan Turner, Baruch Yerushalmi, Michal Kori, et al.
Inflammatory Bowel Diseases|December 4, 2019
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled TrialManar Matar, Raanan Shamir, Dan Turner, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2025
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre StudyRonen Stein, Dan Turner, Séamus Hussey, et al.
Gut|February 9, 2018
Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trialArie Levine, Michal Kori, Jarek Kierkus, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 11, 2014
Genetic and electrophysiological characteristics of recurrent acute pancreatitisSteven Werlin, Fred M Konikoff, Zamir Halpern, et al.
Inflammatory Bowel Diseases|January 26, 2012
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's diseaseRon Shaoul, Marlgozata Sladek, Dan Turner, et al.
Crohn'S & Colitis 360|February 13, 2023
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and ChildrenOhad Atia, Adi Shosberger, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2021
The Effect of Nutritional Therapy on Bone Mineral Density and Bone Metabolism in Pediatric Crohn DiseaseRaffi Lev-Tzion, Tehila Ben-Moshe, Guila Abitbol, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Gastroenterology|June 14, 2019
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive MonitoringAmit Assa, Manar Matar, Dan Turner, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 24, 2020
The Effect of Adalimumab Treatment on Linear Growth in Children With Crohn Disease: A Post-hoc Analysis of the PAILOT Randomized Control TrialManar Matar, Raanan Shamir, Raffi Lev-Zion, et al.
Journal of Crohn'S & Colitis|April 29, 2017
Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled TrialDan Turner, Baruch Yerushalmi, Michal Kori, et al.
Inflammatory Bowel Diseases|December 4, 2019
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled TrialManar Matar, Raanan Shamir, Dan Turner, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2025
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre StudyRonen Stein, Dan Turner, Séamus Hussey, et al.
Gut|February 9, 2018
Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trialArie Levine, Michal Kori, Jarek Kierkus, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 11, 2014
Genetic and electrophysiological characteristics of recurrent acute pancreatitisSteven Werlin, Fred M Konikoff, Zamir Halpern, et al.
Inflammatory Bowel Diseases|January 26, 2012
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's diseaseRon Shaoul, Marlgozata Sladek, Dan Turner, et al.
Crohn'S & Colitis 360|February 13, 2023
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and ChildrenOhad Atia, Adi Shosberger, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2021
The Effect of Nutritional Therapy on Bone Mineral Density and Bone Metabolism in Pediatric Crohn DiseaseRaffi Lev-Tzion, Tehila Ben-Moshe, Guila Abitbol, et al.
Pageof 17